top of page

Curve Biosciences is creating a DNA based blood test to detect and measure chronic illness throughout the body - the first programs will focus on liver disease

  • May 1
  • 1 min read

CEO Ritish Patnaik explains the challenges of understanding DNA in the blood for people who have chronic disease, and the idea behind the company's 'Whole Body Atlas' to make sense of it. Curve will start by creating products that track when cirrhosis transitions to its end stages and cancer, and MASH Monitoring.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page